Keli Walbert

Insider Reports History

Location
Waltham, MA
Signature
/s/ David Watson, attorney-in-fact for Keli Walbert
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Keli Walbert:

Company Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 14,684 $507,804 $33.00 01 Jan 2026 Direct
Apellis Pharmaceuticals, Inc. Director Common Stock 17,051 $402,915 $23.63 01 Jan 2026 Direct
SPRUCE BIOSCIENCES, INC. Director Stock Option (Right to Buy) 3,400 11 Dec 2025 Direct

Insider Reports Filed by Keli Walbert

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APLS Apellis Pharmaceuticals, Inc. 01 Jan 2026 2 $0 4 Director 05 Jan 2026, 16:35
SPRB SPRUCE BIOSCIENCES, INC. 11 Dec 2025 1 $0 4 Director 15 Dec 2025, 18:46
SPRB SPRUCE BIOSCIENCES, INC. 11 Dec 2025 0 $0 3 Director 15 Dec 2025, 18:44
APLS Apellis Pharmaceuticals, Inc. 08 Jan 2025 2 +$507,804 4 Director 10 Jan 2025, 17:39
APLS Apellis Pharmaceuticals, Inc. 08 Jan 2025 0 $0 3 Director 10 Jan 2025, 17:38